A recent SEC Form 4 filing has revealed that Elizabeth L. Walsh, a director at Carter Bankshares, Inc. (NASDAQ: CARE), has increased her direct ownership in the company. On May 6, 2026, Ms. Walsh purchased 4,575 shares of common stock at a price per share of $26.20, resulting in a total transaction value of $119,865.
Following this specific acquisition, Ms. Walsh's direct holdings in Carter Bankshares common stock now total 58,753 shares. Her broader interest in the company is also reflected through various indirect holdings. These include 4,769 shares held via Carriage Square, 367,771 shares through EASG, LLC, and 16,000 shares held through Lester Family Holdings.
The timing of this insider purchase is noteworthy as the stock trades near its 52-week high of $26.39. The equity has seen a substantial climb over the past year, delivering a 69% return. Despite this upward trajectory, InvestingPro analysis indicates that CARE may be trading at a slight premium relative to its estimated Fair Value.
Operational Developments and Asset Management
This insider activity follows several significant operational shifts at Carter Bankshares. The institution recently finalized the sale of nonperforming loans for a total of $289.48 million. These specific loans, which had been reduced to judgments, were linked to entities associated with James C. Justice, II. The sale was executed on an "as-is, where-is" basis to an unaffiliated third party, effectively removing these long-standing issues from the bank's balance sheet.
Prior to this transaction, the loans in question carried an outstanding principal amount of $209.48 million. As of December 31, 2025, the bank had recorded a specific reserve for these loans amounting to $18.04 million.
In addition to the loan sale, Carter Bankshares has resumed its quarterly cash dividend program, a move that marks the first such reinstatement in nearly ten years. The board of directors approved a dividend of $0.10 per share. Shareholders of record as of May 11, 2026, will be eligible to receive the payment on May 25, 2026.
Market Analyst Perspectives
In response to these recent developments, Raymond James has adjusted its outlook for Carter Bank & Trust. The firm maintained an Outperform rating and raised its price target for the stock to $27.00. Analysts at Raymond James attributed this stance to the sale of the Justice nonperforming loans, noting that the transaction helped alleviate a significant overhang that had been affecting both the bank's business operations and its overall stock valuation.